Access cutting-edge heart failure treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access heart failure specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related heart failure treatment provided free
The purpose of this study is to find out if the investigational drug called omecamtiv mecarbil can reduce the risk of the effects of heart failure, like hospitalization, transplantation, or death in patients with heart failure and severely reduced ejection fraction.
Sponsor: Cytokinetics
Check if you qualify for this heart failure clinical trial in Birmingham, AL
If you're searching for heart failure treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced heart failure specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.